MENU
QNCX
AS OF
Nov 13, 04:59 PM (EDT)
Price
$1.68
Change
-$0.04 (-2.34%)
Capitalization
91.85M
110 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
QNCX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Quince Therapeutics (QNCX) Earnings Date & Reports

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

QNCX is expected to report earnings to fall 20.00% to -20 cents per share on March 03

Quince Therapeutics QNCX Stock Earnings Reports
Q4'25
Est.
$-0.20
Q3'25
Missed
by $0.03
Q2'25
Missed
by $0.08
Q1'25
Missed
by $0.15
Q4'24
Missed
by $0.10
The last earnings report on November 12 showed earnings per share of -25 cents, missing the estimate of -21 cents. With 113.87K shares outstanding, the current market capitalization sits at 91.85M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
QNCX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. QNCX showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for QNCX
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com